Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Ramsay Health Care (RHC) vs. Competitors

83 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
AU:RHCRamsay Health CareAUD 54.41AUD 12.31B39.6873.39%HoldUnlock the AU:RHC analyst price target with TipRanks PremiumAU:RHCUnlock the AU:RHC top-analyst price target with TipRanks Premium
AU:HLSHealius LimitedAUD 0.61AUD 421.18M-1.04-31.25%HoldUnlock the AU:HLS analyst price target with TipRanks PremiumAU:RHC vs AU:HLSUnlock the AU:HLS top-analyst price target with TipRanks Premium
AU:REGRegis Healthcare Ltd.AUD 4.77AUD 1.45B25.76-33.57%Moderate BuyUnlock the AU:REG analyst price target with TipRanks PremiumAU:RHC vs AU:REGUnlock the AU:REG top-analyst price target with TipRanks Premium
AU:SHLSonic Healthcare LimitedAUD 21.33AUD 9.92B16.67-0.74%HoldUnlock the AU:SHL analyst price target with TipRanks PremiumAU:RHC vs AU:SHLUnlock the AU:SHL top-analyst price target with TipRanks Premium
AU:IDXIntegral Diagnostics Ltd.AUD 1.66AUD 606.91M27.85-34.65%Moderate BuyUnlock the AU:IDX analyst price target with TipRanks PremiumAU:RHC vs AU:IDXUnlock the AU:IDX top-analyst price target with TipRanks Premium
AU:ACLAustralian Clinical Labs LtdAUD 3.35AUD 621.11M26.9826.42%HoldUnlock the AU:ACL analyst price target with TipRanks PremiumAU:RHC vs AU:ACLUnlock the AU:ACL top-analyst price target with TipRanks Premium

Performance Comparison

-75%-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
AU:RHCRamsay Health Care54.4122.6171.10%
AU:HLSHealius Limited0.60-0.33-35.64%
AU:REGRegis Healthcare Ltd.4.77-2.22-31.76%
AU:SHLSonic Healthcare Limited21.33-0.36-1.64%
AU:IDXIntegral Diagnostics Ltd.1.66-0.81-32.77%
AU:ACLAustralian Clinical Labs Ltd3.350.7227.33%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts